EUVIMEDEUVIMED entdecken
Systematische Übersicht

140 Diagnostic Utility of Urinary Amylase in Acute Pancreatitis: A Systematic Review

U Ullah, S S A Chisthi

British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)

DOI: 10.1093/bjs/znag063.667 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von U Ullah und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the diagnostic accuracy of urinary amylase in acute pancreatitis (AP) by assessing sensitivity, specificity, predictive values, and overall clinical usefulness compared with conventional serum biomarkers.

Method

A systematic search of PubMed, Embase, Scopus, Web of Science, the Cochrane Library, and Google Scholar was performed for studies published from January 2010 to May 2025. Eligible studies included observational, prospective, or diagnostic accuracy designs evaluating urinary amylase or urinary trypsinogen-2 in patients with suspected or confirmed AP. Extracted data included sensitivity, specificity, positive and negative predictive values (PPV, NPV), and area under the curve (AUC). Study quality was assessed using the QUADAS-2 tool.

Results

Thirteen studies, with sample sizes ranging from 51 to 458 participants, met the inclusion criteria. Reported sensitivities ranged from 62.9% to 100%, and specificities ranged from 42.9% to 100%. Several comparative studies showed that urinary biomarkers performed as well as or better than serum amylase and lipase, with AUC values reaching up to 1.0. High NPVs, up to 98.3%, supported their ability to reliably exclude AP. Urinary assays were described as rapid, repeatable, and non-invasive, offering advantages in emergency and resource-limited settings.

Conclusions

Urinary amylase and urinary trypsinogen-2 are sensitive and reliable diagnostic biomarkers for acute pancreatitis, with performance comparable to or exceeding conventional serum markers. Incorporating urinary testing as a first-line or adjunctive diagnostic tool may improve early detection, support evaluation of delayed presentations, and reduce dependence on invasive investigations. Standardised protocols and multicentre validation studies are recommended to optimise clinical integration and practice.

Zitieren

APA

Ullah, U., & Chisthi, S. S. A. (2026). 140 Diagnostic Utility of Urinary Amylase in Acute Pancreatitis: A Systematic Review. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.667

Vancouver

Ullah U, Chisthi SSA. 140 Diagnostic Utility of Urinary Amylase in Acute Pancreatitis: A Systematic Review. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.667

BibTeX
@article{Ullah2026,
  author = {Ullah, U and Chisthi, S S A},
  title = {140 Diagnostic Utility of Urinary Amylase in Acute Pancreatitis: A Systematic Review},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_6},
  doi = {10.1093/bjs/znag063.667}
}
Kostenlos starten →